Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -49.36% | -19.63% | 6.96% | 6.97% | 7.20% |
| Total Other Revenue | 8.36% | 0.09% | -4.26% | -8.82% | -9.65% |
| Total Revenue | 7.36% | -0.22% | -4.09% | -8.59% | -9.40% |
| Cost of Revenue | -3.24% | -6.40% | -4.62% | -3.31% | 5.08% |
| Gross Profit | 68.91% | 32.63% | -1.68% | -27.63% | -49.66% |
| SG&A Expenses | -18.97% | 2.13% | 15.01% | 25.93% | 37.55% |
| Depreciation & Amortization | -5.78% | -2.48% | -8.65% | -7.44% | -7.07% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.70% | -4.06% | -0.07% | 3.18% | 11.88% |
| Operating Income | 69.54% | 23.98% | -29.36% | -167.54% | -3,025.39% |
| Income Before Tax | 38.96% | -116.62% | -387.47% | -744.74% | -65.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.96% | -116.62% | -387.47% | -744.74% | -65.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.96% | -116.62% | -387.47% | -744.74% | -65.75% |
| EBIT | 69.54% | 23.98% | -29.36% | -167.54% | -3,025.39% |
| EBITDA | 84.11% | 30.29% | -48.48% | -454.21% | -584.28% |
| EPS Basic | 39.10% | -114.95% | -378.36% | -764.33% | -64.94% |
| Normalized Basic EPS | 58.74% | 17.99% | -16.53% | -94.26% | -362.70% |
| EPS Diluted | 38.55% | -115.95% | -376.85% | -770.87% | -64.32% |
| Normalized Diluted EPS | 58.74% | 17.99% | -16.53% | -94.26% | -362.70% |
| Average Basic Shares Outstanding | 0.41% | 0.31% | 0.20% | 0.10% | 0.01% |
| Average Diluted Shares Outstanding | 0.41% | 0.31% | 0.20% | 0.10% | 0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 1.00% | 1.00% | -1.00% | 0.86% |